return2ozma@lemmy.world to News@lemmy.world · 7 months agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square153fedilinkarrow-up1616arrow-down117cross-posted to: [email protected][email protected][email protected][email protected][email protected][email protected][email protected][email protected][email protected]
arrow-up1599arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 7 months agomessage-square153fedilinkcross-posted to: [email protected][email protected][email protected][email protected][email protected][email protected][email protected][email protected][email protected]
minus-squareMarcbmann@lemmy.worldlinkfedilinkarrow-up2·edit-27 months agoNovo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.
Novo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.